The effect of whey peptide in elderly obese patients

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200057152

Enrollment

Unknown

Registered

2022-03-01

Start date

2019-07-01

Completion date

Unknown

Last updated

2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elder obese

Interventions

whey peptide group:whey peptide

whey protein group:whey protein

probiotic group:probiotics

calorie-restrict group:calorie-restrict

control group:health education

Eligibility

Sex/Gender

All

Age

50 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Local obese patients aged 50-80 years. 2. Obesity was diagnosed by body fat content: >=25% for men and >=35% for women.

Exclusion criteria

Exclusion criteria: 1. Mobility or cognitive impairment; 2. Patients with liver decompensation, severely impaired renal function (CrCI < 30ml/min), tumor, cardiopulmonary insufficiency, gastrointestinal absorption dysfunction and other diseases; 3. Use of ACEI drugs; 4. The follow-up could not be completed within 3 months of living out.

Design outcomes

Primary

Measure	Time frame
body composition;inflammation indicator;intestinal flora;	—

Countries

China

Contacts

Public ContactQin Liqiang

qinliqiang@suda.edu.cn+86 13915543146

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026